148 related articles for article (PubMed ID: 16849685)
1. Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk.
Fletcher O; Johnson N; Palles C; dos Santos Silva I; McCormack V; Whittaker J; Ashworth A; Peto J
J Natl Cancer Inst; 2006 Jul; 98(14):1014-8. PubMed ID: 16849685
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of the STK15 F31I polymorphism and its relationship with mammographic density.
Giacomazzi J; Aguiar E; Palmero EI; Schmidt AV; Skonieski G; Duarte Filho D; Bock H; Saraiva-Pereira ML; Schuler-Faccini L; Camey SA; Caleffi M; Giugliani R; Ashton-Prolla P
Braz J Med Biol Res; 2011 Apr; 44(4):291-6. PubMed ID: 21412660
[TBL] [Abstract][Full Text] [Related]
3. Two nonsynonymous polymorphisms (F31I and V57I) of the STK15 gene and breast cancer risk: a meta-analysis based on 5966 cases and 7609 controls.
Qin K; Wu C; Wu X
J Int Med Res; 2013 Aug; 41(4):956-63. PubMed ID: 23803310
[TBL] [Abstract][Full Text] [Related]
4. Functional Phe31Ile polymorphism in Aurora A and risk of breast carcinoma.
Sun T; Miao X; Wang J; Tan W; Zhou Y; Yu C; Lin D
Carcinogenesis; 2004 Nov; 25(11):2225-30. PubMed ID: 15271856
[TBL] [Abstract][Full Text] [Related]
5. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types.
Ewart-Toland A; Dai Q; Gao YT; Nagase H; Dunlop MG; Farrington SM; Barnetson RA; Anton-Culver H; Peel D; Ziogas A; Lin D; Miao X; Sun T; Ostrander EA; Stanford JL; Langlois M; Chan JM; Yuan J; Harris CC; Bowman ED; Clayman GL; Lippman SM; Lee JJ; Zheng W; Balmain A
Carcinogenesis; 2005 Aug; 26(8):1368-73. PubMed ID: 15802297
[TBL] [Abstract][Full Text] [Related]
6. STK15 polymorphisms and association with risk of invasive ovarian cancer.
Dicioccio RA; Song H; Waterfall C; Kimura MT; Nagase H; McGuire V; Hogdall E; Shah MN; Luben RN; Easton DF; Jacobs IJ; Ponder BA; Whittemore AS; Gayther SA; Pharoah PD; Kruger-Kjaer S
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1589-94. PubMed ID: 15466974
[TBL] [Abstract][Full Text] [Related]
7. Case-control, kin-cohort and meta-analyses provide no support for STK15 F31I as a low penetrance colorectal cancer allele.
Webb EL; Rudd MF; Houlston RS
Br J Cancer; 2006 Oct; 95(8):1047-9. PubMed ID: 17003782
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer.
Dai Q; Cai QY; Shu XO; Ewart-Toland A; Wen WQ; Balmain A; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2065-70. PubMed ID: 15598762
[TBL] [Abstract][Full Text] [Related]
9. STK15 polymorphism and breast cancer risk in a population-based study.
Egan KM; Newcomb PA; Ambrosone CB; Trentham-Dietz A; Titus-Ernstoff L; Hampton JM; Kimura MT; Nagase H
Carcinogenesis; 2004 Nov; 25(11):2149-53. PubMed ID: 15271853
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians.
Gu J; Gong Y; Huang M; Lu C; Spitz MR; Wu X
Carcinogenesis; 2007 Feb; 28(2):350-5. PubMed ID: 16926177
[TBL] [Abstract][Full Text] [Related]
11. Association between the STK15 polymorphisms and risk of cancer: a meta-analysis.
Qin J; He XF; Wei W; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ
Mol Genet Genomics; 2015 Feb; 290(1):97-114. PubMed ID: 25154511
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States).
Cox DG; Hankinson SE; Hunter DJ
Cancer Causes Control; 2006 Feb; 17(1):81-3. PubMed ID: 16411056
[TBL] [Abstract][Full Text] [Related]
13. Lack of an association between AURKA T91A polymorphisms and breast cancer: a meta-analysis involving 32,141 subjects.
Sun H; Bai J; Chen F; Jin Y; Yu Y; Fu S
Breast Cancer Res Treat; 2011 Jan; 125(1):175-9. PubMed ID: 20464476
[TBL] [Abstract][Full Text] [Related]
14. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
Couch FJ; Sinilnikova O; Vierkant RA; Pankratz VS; Fredericksen ZS; Stoppa-Lyonnet D; Coupier I; Hughes D; Hardouin A; Berthet P; Peock S; Cook M; Baynes C; Hodgson S; Morrison PJ; Porteous ME; Jakubowska A; Lubinski J; Gronwald J; Spurdle AB; ; Schmutzler R; Versmold B; Engel C; Meindl A; Sutter C; Horst J; Schaefer D; Offit K; Kirchhoff T; Andrulis IL; Ilyushik E; Glendon G; Devilee P; Vreeswijk MP; Vasen HF; Borg A; Backenhorn K; Struewing JP; Greene MH; Neuhausen SL; Rebbeck TR; Nathanson K; Domchek S; Wagner T; Garber JE; Szabo C; Zikan M; Foretova L; Olson JE; Sellers TA; Lindor N; Nevanlinna H; Tommiska J; Aittomaki K; Hamann U; Rashid MU; Torres D; Simard J; Durocher F; Guenard F; Lynch HT; Isaacs C; Weitzel J; Olopade OI; Narod S; Daly MB; Godwin AK; Tomlinson G; Easton DF; Chenevix-Trench G; Antoniou AC;
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1416-21. PubMed ID: 17627006
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK.
Lo YL; Yu JC; Chen ST; Yang HC; Fann CS; Mau YC; Shen CY
Int J Cancer; 2005 Jun; 115(2):276-83. PubMed ID: 15688402
[TBL] [Abstract][Full Text] [Related]
16. [Genetic polymorphisms in STK15 and MMP-2 associated susceptibility to esophageal cancer in Mongolian population].
Chen XB; Chen GL; Liu JN; Yang JZ; Yu DK; Lin DX; Tan W
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):559-64. PubMed ID: 19954064
[TBL] [Abstract][Full Text] [Related]
17. Association between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43,626 subjects.
Tang W; Qiu H; Ding H; Sun B; Wang L; Yin J; Gu H
PLoS One; 2013; 8(12):e82790. PubMed ID: 24349361
[TBL] [Abstract][Full Text] [Related]
18. Functional STK15 Phe31Ile polymorphism is associated with the occurrence and advanced disease status of esophageal squamous cell carcinoma.
Miao X; Sun T; Wang Y; Zhang X; Tan W; Lin D
Cancer Res; 2004 Apr; 64(8):2680-3. PubMed ID: 15087379
[TBL] [Abstract][Full Text] [Related]
19. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
[TBL] [Abstract][Full Text] [Related]
20. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
Xie D; Shu XO; Deng Z; Wen WQ; Creek KE; Dai Q; Gao YT; Jin F; Zheng W
J Natl Cancer Inst; 2000 Mar; 92(5):412-7. PubMed ID: 10699071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
